Pharming Group Stock Forecast - 20 Period Moving Average

PHARM Stock  EUR 0.73  0.01  1.39%   
The 20 Period Moving Average forecasted value of Pharming Group NV on the next trading day is expected to be 0.74 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 1.85. Pharming Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pharming Group stock prices and determine the direction of Pharming Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pharming Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A commonly used 20-period moving average forecast model for Pharming Group NV is based on a synthetically constructed Pharming Groupdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Pharming Group 20 Period Moving Average Price Forecast For the 27th of November

Given 90 days horizon, the 20 Period Moving Average forecasted value of Pharming Group NV on the next trading day is expected to be 0.74 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 1.85.
Please note that although there have been many attempts to predict Pharming Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pharming Group's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Pharming Group Stock Forecast Pattern

Backtest Pharming GroupPharming Group Price PredictionBuy or Sell Advice 

Pharming Group Forecasted Value

In the context of forecasting Pharming Group's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Pharming Group's downside and upside margins for the forecasting period are 0.01 and 3.88, respectively. We have considered Pharming Group's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.73
0.74
Expected Value
3.88
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Pharming Group stock data series using in forecasting. Note that when a statistical model is used to represent Pharming Group stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria77.141
BiasArithmetic mean of the errors -0.006
MADMean absolute deviation0.0441
MAPEMean absolute percentage error0.0579
SAESum of the absolute errors1.8515
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Pharming Group NV 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Pharming Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharming Group NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.040.733.85
Details
Intrinsic
Valuation
LowRealHigh
0.030.623.74
Details

Other Forecasting Options for Pharming Group

For every potential investor in Pharming, whether a beginner or expert, Pharming Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharming Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharming. Basic forecasting techniques help filter out the noise by identifying Pharming Group's price trends.

Pharming Group Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharming Group stock to make a market-neutral strategy. Peer analysis of Pharming Group could also be used in its relative valuation, which is a method of valuing Pharming Group by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pharming Group NV Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pharming Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pharming Group's current price.

Pharming Group Market Strength Events

Market strength indicators help investors to evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By undertsting and applying Pharming Group stock market strength indicators, traders can identify Pharming Group NV entry and exit signals to maximize returns.

Pharming Group Risk Indicators

The analysis of Pharming Group's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharming stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Information and Resources on Investing in Pharming Stock

When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Pharming Group to cross-verify your projections.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Please note, there is a significant difference between Pharming Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharming Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharming Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.